N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide

C116H135N15O5S — CID 157087885

IUPACN-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide
SMILESC=CCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1cccc(C)c1.C=CCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1ccccc1.CCCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1ccc(C)s1.CCCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1cccc(C)c1.CCCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1ccccc1
InChIInChI=1S/C24H29N3O.C24H27N3O.C23H27N3O.C23H25N3O.C22H27N3OS/c2*1-3-15-26(24(28)19-10-8-9-18(2)16-19)17-23-25-21-13-6-7-14-22(21)27(23)20-11-4-5-12-20;2*1-2-16-25(23(27)18-10-4-3-5-11-18)17-22-24-20-14-8-9-15-21(20)26(22)19-12-6-7-13-19;1-3-14-24(22(26)20-13-12-16(2)27-20)15-21-23-18-10-6-7-11-19(18)25(21)17-8-4-5-9-17/h6-10,13-14,16,20H,3-5,11-12,15,17H2,1-2H3;3,6-10,13-14,16,20H,1,4-5,11-12,15,17H2,2H3;3-5,8-11,14-15,19H,2,6-7,12-13,16-17H2,1H3;2-5,8-11,14-15,19H,1,6-7,12-13,16-17H2;6-7,10-13,17H,3-5,8-9,14-15H2,1-2H3
InChIKeyAEHMSQKNHFYUMP-UHFFFAOYSA-N
MW1851.52 g/mol
LogP26.56
Rot. Bonds30

About N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide

N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide (PubChem CID 157087885) has the molecular formula C116H135N15O5S and a molecular weight of 1851.52 g/mol. Its IUPAC name is N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide.

Molecular Properties

Compound NameN-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide
PubChem CID157087885
Molecular FormulaC116H135N15O5S
Molecular Weight1851.52 g/mol
Exact Mass1850.05
IUPAC NameN-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide
SMILESC=CCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1cccc(C)c1.C=CCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1ccccc1.CCCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1ccc(C)s1.CCCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1cccc(C)c1.CCCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1ccccc1
InChIInChI=1S/C24H29N3O.C24H27N3O.C23H27N3O.C23H25N3O.C22H27N3OS/c2*1-3-15-26(24(28)19-10-8-9-18(2)16-19)17-23-25-21-13-6-7-14-22(21)27(23)20-11-4-5-12-20;2*1-2-16-25(23(27)18-10-4-3-5-11-18)17-22-24-20-14-8-9-15-21(20)26(22)19-12-6-7-13-19;1-3-14-24(22(26)20-13-12-16(2)27-20)15-21-23-18-10-6-7-11-19(18)25(21)17-8-4-5-9-17/h6-10,13-14,16,20H,3-5,11-12,15,17H2,1-2H3;3,6-10,13-14,16,20H,1,4-5,11-12,15,17H2,2H3;3-5,8-11,14-15,19H,2,6-7,12-13,16-17H2,1H3;2-5,8-11,14-15,19H,1,6-7,12-13,16-17H2;6-7,10-13,17H,3-5,8-9,14-15H2,1-2H3
InChIKeyAEHMSQKNHFYUMP-UHFFFAOYSA-N
XLogP26.56
TPSA190.65 Ų
H-Bond Donors
H-Bond Acceptors16
Rotatable Bonds30
Heavy Atoms137
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001851.52
LogP ≤ 526.56
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide?
The IUPAC name of N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide (CID 157087885) is N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide.
What is the SMILES notation for N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide?
The canonical SMILES for N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide is C=CCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1cccc(C)c1.C=CCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1ccccc1.CCCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1ccc(C)s1.CCCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1cccc(C)c1.CCCN(Cc1nc2ccccc2n1C1CCCC1)C(=O)c1ccccc1.
What is the InChIKey of N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide?
The InChIKey is AEHMSQKNHFYUMP-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H29N3O.C24H27N3O.C23H27N3O.C23H25N3O.C22H27N3OS/c2*1-3-15-26(24(28)19-10-8-9-18(2)16-19)17-23-25-21-13-6-7-14-22(21)27(23)20-11-4-5-12-20;2*1-2-16-25(23(27)18-10-4-3-5-11-18)17-22-24-20-14-8-9-15-21(20)26(22)19-12-6-7-13-19;1-3-14-24(22(26)20-13-12-16(2)27-20)15-21-23-18-10-6-7-11-19(18)25(21)17-8-4-5-9-17/h6-10,13-14,16,20H,3-5,11-12,15,17H2,1-2H3;3,6-10,13-14,16,20H,1,4-5,11-12,15,17H2,2H3;3-5,8-11,14-15,19H,2,6-7,12-13,16-17H2,1H3;2-5,8-11,14-15,19H,1,6-7,12-13,16-17H2;6-7,10-13,17H,3-5,8-9,14-15H2,1-2H3.
What are the key properties of N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide?
N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide has a molecular weight of 1851.52 g/mol, XLogP of 26.56, 30 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-3-methyl-N-propylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-5-methyl-N-propylthiophene-2-carboxamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-prop-2-enylbenzamide;N-[(1-cyclopentylbenzimidazol-2-yl)methyl]-N-propylbenzamide is sourced from PubChem (CID 157087885), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).